HNWAG
COGT icon

High Net Worth Advisory Group’s Cogent Biosciences COGT Stock Holding History

High Net Worth Advisory Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$22K – 638
2022
Q3 		$22K Hold
1,500
– – 0.01% 437
2022
Q2 		$14K Hold
1,500
– – 0.01% 492
2022
Q1 		$11K Hold
1,500
– – ﹤0.01% 517
2021
Q4 		$13K Buy
+1,500
New +$13K ﹤0.01% 512

Other funds holding COGT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

High Net Worth Advisory Group's COGT Position: Q4 2022 in Review

High Net Worth Advisory Group sold out of Cogent Biosciences (COGT) in Q4 2022, closing a stake of 1,500 shares — an estimated $22K sold.

High Net Worth Advisory Group first reported a position in COGT in Q4 2021 and held it in 4 quarters. The position peaked at $22K in Q3 2022. 135 funds tracked by Wall St. Rank hold COGT as of Q4 2022.

  • High Net Worth Advisory Group reported no remaining Cogent Biosciences position as of Q4 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 1,500 Cogent Biosciences shares in Q4 2022, an estimated $22K.
  • High Net Worth Advisory Group first reported a position in Cogent Biosciences in Q4 2021 and held it in 4 quarters.
  • High Net Worth Advisory Group's Cogent Biosciences position peaked at $22K in Q3 2022.
  • 135 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2022.

Based on High Net Worth Advisory Group's 13F filing for Q4 2022, filed 14 Feb 2023.